Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Sep:122:108204.
doi: 10.1016/j.yebeh.2021.108204. Epub 2021 Jul 23.

Dynamic FDG-PET in localization of focal epilepsy: A pilot study

Affiliations

Dynamic FDG-PET in localization of focal epilepsy: A pilot study

Vikram Seshadri et al. Epilepsy Behav. 2021 Sep.

Abstract

Epilepsy surgery remains underutilized, in part because non-invasive methods of potential seizure foci localization are inadequate. We used high-resolution, parametric quantification from dynamic 2-[18F] fluoro-2-deoxy-d-glucose positron emission tomography (dFDG-PET) imaging to locate hypometabolic foci in patients whose standard clinical static PET images were normal. We obtained dFDG-PET brain images with simultaneous EEG in a one-hour acquisition on seven patients with no MRI evidence of focal epilepsy to record uptake and focal radiation decay. Images were attenuation- and motion-corrected and co-registered with high-resolution T1-weighted patient MRI and segmented into 18 regions of interest (ROI) per hemisphere. Tracer uptake was calibrated with a model corrected blood input function with partial volume (PV) corrections to generate tracer parametric maps compared between mean radiation values between hemispheres with z-scores. We identified ROI with the lowest negative z scores (<-1.65 SD) as hypometabolic. Dynamic 2-[18F] fluoro-2-deoxy-d-glucose positron emission tomography ( found focal regions of altered metabolism in all cases in which standard clinical FDG-PET found no abnormalities. This pilot study of dynamic FDG-PET suggests that further research is merited to evaluate whether glucose dynamics offer improved clinical utility for localization of epileptic foci over standard static techniques.

Keywords: Cerebral metabolism; Epilepsy surgery; Focal epilepsy; Neuroimaging.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest None of the authors has any conflict of interest to disclose. We confirm that we have read the Journal’s position on issues involved in ethical publication and affirm that this report is consistent with those guidelines.

Figures

Fig. 1.
Fig. 1.
Steps in dynamic FDG-PET image acquisition, pre-processing, and parametric map creation. Dynamic PET, high-resolution MR and Destrieux Atlas defined on the MR brain template form the raw inputs (A–D). The motion corrected dynamic PET data are Co-Registered with patient MR followed by co-registration of MR image with a high-resolution T1-weighted MR brain template provided by the Montreal Neurological Institute using nonrigid transform (E). Model corrected blood input function (MCIF) is then computed from the internal carotid arteries for all patients (F). Each voxel of dynamic PET data along with blood input is independently fed into a graphical Patlak model to compute parametric Ki maps using linear regression and subsequently z score maps (G). The co-registered template and atlas was used to bin individual voxels of the generated uptake maps for regional analyses (H).
Fig. 2.
Fig. 2.
Regional z score maps of dFDG-PET co-registered on MRI for all 7 patients indicating temporal lobe hypometabolism. Inclusion criteria required normal standard sFDG-PET.

Similar articles

Cited by

References

    1. Engel J, Wiebe S, French J, Sperling M, Williamson P, Spencer D, et al.. Practice parameter: temporal lobe and localized neocortical resections for epilepsy: report of the Quality Standards Subcommittee of the American Academy of Neurology, in Association with the American Epilepsy Society and the American Association of Neurological Surgeons. Neurology 2003;60:538–47. - PubMed
    1. Rathore C, Dickson JC, Teotónio R, Ell P, Duncan JS. The utility of 18 F-fluorodeoxyglucose PET (FDG PET) in epilepsy surgery. Epilepsy Res 2014;108:1306–14. - PubMed
    1. Téllez-Zenteno JF, Ronquillo LH, Moien-Afshari F, Wiebe S. Surgical outcomes in lesional and non-lesional epilepsy: a systematic review and meta-analysis. Epilepsy Res 2010;89:310–8. - PubMed
    1. Yang PF, Pei JS, Zhang HJ, Lin Q, Mei Z, Zhong ZH, et al.. Long-term epilepsy surgery outcomes in patients with PET-positive, MRI-negative temporal lobe epilepsy. Epilepsy Behav 2014;41:91–7. - PubMed
    1. Muhlhofer W, Tan YL, Mueller SG, Knowlton R. MRI-negative temporal lobe epilepsy-What do we know? Epilepsia 2017;58:727–42. - PubMed

Publication types

Substances